Blume Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30 Buy
+5
New +$38 ﹤0.01% 336
2022
Q3
Sell
-93
Closed -$3K 325
2022
Q2
$3K Buy
+93
New +$3.26K ﹤0.01% 290
2021
Q4
Sell
-40
Closed -$1K 312
2021
Q3
$1K Sell
40
-170
-81% -$5.44K ﹤0.01% 298
2021
Q2
$6K Buy
+210
New +$6.91K ﹤0.01% 255

Other funds holding OGN

Blume Capital Management's OGN Position: Q1 2026 in Review

Blume Capital Management opened a new position in Organon & Co (OGN) in Q1 2026: 5 shares worth $30. The stake represents ﹤0.01% of the portfolio and ranks #336 among its holdings. This is a return to the name: Blume Capital Management previously reported a position in OGN as recently as Q2 2022.

Blume Capital Management first reported a position in OGN in Q2 2021 and has held it in 4 quarters since. The position peaked at $6K in Q2 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Blume Capital Management held 5 shares of Organon & Co worth $30 as of Q1 2026.
  • Organon & Co was a new Blume Capital Management position in Q1 2026.
  • Organon & Co made up ﹤0.01% of Blume Capital Management's portfolio in Q1 2026, its #336 holding.
  • Blume Capital Management first reported a position in Organon & Co in Q2 2021 and has held it in 4 quarters since.
  • Blume Capital Management's Organon & Co position peaked at $6K in Q2 2021.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Blume Capital Management's 13F filing for Q1 2026, filed 1 May 2026.